{"author": "Liu, XX ", "adress": "Southern Med Univ, Zhujiang Hosp, Dept Pharm, Guangzhou 510282, Guangdong, Peoples R China", "emails": ["lxx913@163.com"], "title": "The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells"}